Advertisement

Insulin and atherosclerosis

Chapter
  • 42 Downloads

Abstract

This chapter will discuss clinical and epidemiological evidence that elevated insulin levels are associated with atherosclerosis and its complications. Evidence that insulin has biological actions on the arterial wall which may be relevant to the development of atheromatous lesions is discussed in Chapter 7.

Keywords

Insulin Level Oral Glucose Ischaemic Heart Disease Insulin Response Basal Insulin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Porte, D., Jr and Bagdade, J. (1970). Human insulin secretion: an integrated approach. Annu. Rev. Med., 21, 219PubMedCrossRefGoogle Scholar
  2. 2.
    Bagdade, J. D., Bierman, E. L. and Porte, D., Jr (1967). The significance of basal insulin levels in evaluation of the insulin response to glucose in diabetic and non-diabetic subjects. J. Clin. Invest., 46, 1549PubMedCrossRefGoogle Scholar
  3. 3.
    Pyke, D. A. and Please, N. W. (1957). Obesity, parity and diabetes. J. Endocrinol., 15, xxviPubMedGoogle Scholar
  4. 4.
    Danowski, T. S., Lombardo, Y. B., Mendelsohn, L. V., Corredor, D. G., Morgan, C. R. and Sabeh, G. (1969). Insulin patterns prior to and after onset of diabetes. Metabolism, 18, 731PubMedCrossRefGoogle Scholar
  5. 5.
    Jackson, W. P. U., van Mieghem, W. and Keller, P. (1972). Insulin excess as the initial lesion in diabetes. Lancet, 1, 1040PubMedCrossRefGoogle Scholar
  6. 6.
    Reaven, G. M., Olefsky, J. and Farquhar, J. W. (1972). Does hyperglycaemia or hyperinsulinaemia characterise the patient with chemical diabetes. Lancet, 1, 1247PubMedCrossRefGoogle Scholar
  7. 7.
    Savage, P. J., Dippe, S. E., Bennett, P. H., Gordon, P., Roth, J., Rushforth, N. B. and Miller, M. (1975). Hyperinsulinemia and hypoinsulinemia. Insulin reponses to oral carbohydrate over a wide spectrum of glucose tolerance. Diabetes, 24, 363CrossRefGoogle Scholar
  8. 8.
    Reinheimer, W., Bliffen, G., McCoy, J., Wallace, D. and Albrink, M.J. (1967). Weight gain, serum lipids, and vascular disease in diabetics. Am. J. Clin. Nutr., 20, 986PubMedGoogle Scholar
  9. 9.
    Santen, R. J., Willis, P. W. and Fajans, S. S. (1972). Atherosclerosis in diabetes mellitus. Arch. Intern. Med., 130, 833PubMedCrossRefGoogle Scholar
  10. 10.
    Goodner, C. J. and Porte, D., Jr (1972). Determinants of basal insulin secretion in man. In Handbook of Physiology. Section 7, Part 1, pp. 597–609. (Washington, DC: American Physiological Society)Google Scholar
  11. 11.
    Werther, G. A., Jenkins, P. A., Turner, R. C. and Baum, J. D. (1980). Twenty-four-hour metabolic profiles in diabetic children receiving insulin injections once or twice daily. Br. Med., 2, 414CrossRefGoogle Scholar
  12. 12.
    Blackard, W. G. and Nelson, N. C. (1970). Portal and peripheral vein immunoreactive insulin concentrations before and after glucose infusion. Diabetes, 19, 302PubMedGoogle Scholar
  13. 13.
    Rasmussen, S. M., Heding, I. G. and Parbst, E. (1975). Serum IRI in insulin-treated diabetics during a 24-hour period. Diabetologia, 11, 151PubMedCrossRefGoogle Scholar
  14. 14.
    Grodsky, G. M. (1965). Production of autoantibodies to insulin in man and rabbits. Diabetes, 14, 396PubMedGoogle Scholar
  15. 15.
    Pearson, M. J. and Martin, F. I. R. (1970). The separation of total plasma insulin from binding proteins using gel filtration: its application to the measurement of rate of insulin disappearance. Diabetologia, 6, 581PubMedCrossRefGoogle Scholar
  16. 16.
    Heding, L. G. (1972). Determination of total serum insulin (IRI) in insulin-treated diabetic patients. Diabetologia, 8, 260PubMedCrossRefGoogle Scholar
  17. 17.
    Gennaro, W. D. and Van Norman, J. D. (1975). Quantitation of free, total and antibody- bound insulin in insulin-treated diabetics. Clin. Chem., 21, 873PubMedGoogle Scholar
  18. 18.
    Nakagawa, S., Nakayama, H., Sasaki, T., Yoshino, K., Yu, Y. Y., Shinozaki, K., Aoki, S. and Mashimo, K. (1973). A simple method for the determination of serum free insulin levels in insulin-treated patients. Diabetes, 22, 590PubMedGoogle Scholar
  19. 19.
    Kashyap, L., Magill, F., Rojes, L. and Hoffman, M. M. (1970). Insulin and non-esterified fatty acid metabolism in asymptomatic diabetics and atherosclerotic subjects. Can. Med. Assoc. J., 102, 1165PubMedGoogle Scholar
  20. 20.
    Stout, R. W. (1977). The relationship of abnormal circulating insulin levels to atherosclerosis. Atherosclerosis, 27, 1PubMedCrossRefGoogle Scholar
  21. 21.
    Peters, N. and Hales, C. N. (1965). Plasma insulin concentrations after myocardial infarction. Lancet, 1, 1144PubMedCrossRefGoogle Scholar
  22. 22.
    Nikkila, E. A., Miettinen, A. A., Vesenne, M. R. and Pelkonen, R. (1965). Plasma insulin in coronary heart disease. Lancet, 2, 508PubMedCrossRefGoogle Scholar
  23. 23.
    Tzagournis, M., Chiles, R., Ryan, J. M. and Skillman, T. G. (1968). Interrelationships of hyperinsulinism and hypertriglyceridemia in young patients in coronary heart disease. Circulation, 38, 1156PubMedGoogle Scholar
  24. 24.
    Christiansen, I., Derkert, T., Kjerulf, K., Mitgaard, K. and Worning, H. (1968). Glucose tolerance, plasma lipids and serum insulin in patients with ischaemic heart disease. Acta Med. Scand., 184, 283PubMedCrossRefGoogle Scholar
  25. 25.
    Malherbe, C., De Gasparo, M., Berthet, P., De Hertogh, R. and Hoet, J. J. (1970). The pattern of plasma insulin response to glucose in patients with a previous myocardial infarction - the respective effects of age and disease. Eur. J. Clin. Invest., 1, 265Google Scholar
  26. 26.
    Gertler, M. M., Leetma, H. E., Saluste, E., Rosenberger, J. L. and Guthrie, R. G. (1972). Ischaemic heart disease — insulin, carbohydrate and lipid interrelationships. Circulation, 46, 103PubMedGoogle Scholar
  27. 27.
    Sorge, F., Schwartzkopff, W. and Neuhaus, G. A. (1976). Insulin response to oral glucose in patients with a previous myocardial infarction and in patients with peripheral vascular disease. Diabetes, 25, 586PubMedCrossRefGoogle Scholar
  28. 28.
    Gertler, M. M., Leetma, H. E., Saiuste, E., Covalt, D. A. and Rosenberger, J. L. (1972). Covert diabetes mellitus ischaemic heart and cerebrovascular disease. Geriatrics, 27, 105PubMedGoogle Scholar
  29. 29.
    Sloan, J. M., Mackay, J. S. and Sheridan, B. (1971). The incidence of plasma insulin, blood sugar and serum lipid abnormalities in patients with atherosclerotic disease. Diabetologia, 7, 431PubMedCrossRefGoogle Scholar
  30. 30.
    Welborn, T. A., Breckenbridge, A., Rubenstein, A. H., Dollery, C. T. and Fraser, T. R. (1966). Serum-insulin in essential hypertension and peripheral vascular disease. Lancet, 1, 1336PubMedCrossRefGoogle Scholar
  31. 31.
    Taylor, S. H. and Majid, P. A. (1971). Insulin and the heart. J. Molec. Cell. Cardiol., 2, 293CrossRefGoogle Scholar
  32. 32.
    Ostrander, L. D., Neff, B. J., Block, W. D., Francis, T. and Epstein, F. H. (1967). Hyperglycemia and hypertriglyceridemia among persons with coronary heart disease. Ann. Intern. Med., 67, 34PubMedGoogle Scholar
  33. 33.
    Carlson, L. A. and Bottiger, O. E. (1972). Ischaemic heart disease in relation to fasting values of plasma triglycerides and cholesterol. Lancet, 1, 865PubMedCrossRefGoogle Scholar
  34. 34.
    Bierman, E. L., Porte, D., Jr and Bagdade, J. D. (1970). Hypertriglyceridemia and glucose intolerance in man. In Jeanrenaud, B. and Hepp, D. (eds.) Adipose Tissue, pp. 209–12. (New York: Academic Press)Google Scholar
  35. 35.
    Olefsky, J. M., Farquhar, J. W. and Reaven, G. M. (1974). Reappraisal of the role of insulin in hypertriglyceridemia. Am. J. Med., 57, 551PubMedCrossRefGoogle Scholar
  36. 36.
    Topping, D. L. and Mayes, P. A. (1972). The immediate effects of insulin and fructose on the metabolism of the perfused liver — changes in lipoprotein secretion, fatty acid oxidation and esterification, lipogenesis and carbohydrate metabolism. Biochem. J., 126, 295Google Scholar
  37. 37.
    Bagdade, J. D., Porte, D., Jr and Bierman, E. L. (1968). Acute insulin withdrawal and the regulation of plasma triglyceride removal in diabetic subjects. Diabetes, 17, 127PubMedGoogle Scholar
  38. 38.
    Renold, A. E., Crofford, O. B., Stauffacher, W. and Jeanrenaud, B. (1965). Hormonal control of adipose tissue metabolism, with special reference to the effects of insulin. Diabetologia, 1, 4CrossRefGoogle Scholar
  39. 39.
    Society of Actuaries (1959). Build and Blood Pressure Study. (Chicago: Society of Actuaries)Google Scholar
  40. 40.
    Lindner, A., Charra, B., Sherrard, D. J. and Scribner, B. H. (1974). Accelerated atherosclerosis in prolonged maintenance hemodialysis. N. Engl. J. Med., 290, 697PubMedCrossRefGoogle Scholar
  41. 41.
    Bagdade, J. D. (1975). Disorders of carbohydrate and lipid metabolism in uremia. Nephron, 14, 153PubMedCrossRefGoogle Scholar
  42. 42.
    Bagdade, J. D. (1970). Uremic lipemia. Arch. Intern. Med., 126, 875PubMedCrossRefGoogle Scholar
  43. 43.
    Rubenstein, A. H., Seftel, H. C., Miller, K., Bersohn, I. and Wright, A. D. (1969). Metabolic responses to oral glucose in healthy South African white, Indian and African subjects. Br. Med. J., 1, 748PubMedCrossRefGoogle Scholar
  44. 44.
    Logan, R. L., Thomson, M., Riemersma, R. A., Oliver, M. F., Olsson, A. G., Rossner, S., Callmer, E., Walldius, G., Kaijser, L., Carlson, L. A., Lockerbie, L. and Lutz, W. (1978). Risk factors for ischaemic heart disease in normal men aged 40 (EdinburghStockholm Study). Lancet, 1, 949PubMedCrossRefGoogle Scholar
  45. 45.
    Pyorala, K. (1979). Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care, 2, 131PubMedCrossRefGoogle Scholar
  46. 46.
    Ducimetiere, P., Eschwege, L., Papoz, J. L., Claude, R. J. R. and Rosselin, G. (1980). Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia, 19, 205PubMedCrossRefGoogle Scholar
  47. 47.
    Welborn, T. A. and Wearne, K. (1979). Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care, 2, 154PubMedCrossRefGoogle Scholar
  48. 48.
    Stout, R. W. and Vallance-Owen, J. (1969). Insulin and atheroma. Lancet, 1, 1078PubMedCrossRefGoogle Scholar
  49. 49.
    Stout, R. W. (1979). Diabetes and atherosclerosis — the role of insulin. Diabetologia, 16, 141PubMedCrossRefGoogle Scholar

Copyright information

© R. W. Stout 1982

Authors and Affiliations

  1. 1.The Queen’s University of BelfastUK

Personalised recommendations